NL-OMON46958已完成3 期
HD 18 for advanced stages: treatment optimization trial in the first line treatment of advanced stage Hodgkin Lymphoma; treatment stratification by means of FDG-PET. - HD 18
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1.Histologically proven primary diagnosis of Hodgkin lymphoma;
- •2.1 CS (PS) IIB with one or both of the following risk factors:
- •a) Large mediastinal mass (><= 1/3 of the maximum transverse diameter of the
- •b) Extranodal lesions (see definition in section 14.3.4);
- •2.2 CS (PS) III, IV;
- •3. Patient had no previous treatment for HL;
- •4. Age at entry: 18 - 60 years;
- •5. 6. Normal organ function (except HL-related);
- •6. Negative HIV test
- •7. In women: negative pregnancy test
- •8. Life expectancy > 3 months.
排除标准
- •1. Incomplete diagnosis of the disease stage;
- •2. Prior or concurrent disease that prevents treatment according to protocol;
- •3. HL as composite lymphoma;
- •4. Prior chemotherapy or radiation;
- •5. Malignant disease within the last 5 years (exceptions: basalioma, carcinoma in
- •situ of the cervix uteri, completely resected melanoma TNMpT1);
- •6. Pregnancy, lactation;
- •7. WHO activity index > 2;
- •8. Long-term ingestion of corticosteroids (e.g. for chronic polyarthritis) or
- •antineoplastic drugs (e.g. methotrexate)
研究者
相似试验
进行中（未招募）
1 期
HD 18 for advanced stages: treatment optimization trial in the first line treatment of advanced stage Hodgkin Lymphoma; treatment stratification by means of FDG-PET. - HD 18Hodgkin's Lymphoma advanced stageEUCTR2007-003187-22-NLVU University Medical Center2,101
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatment of advanced stage Hodgkin lymphomaTreatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-005130-55-DEniversity of Cologne1,500
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatmend of advanced stage Hodgkin lymphomaEUCTR2014-005130-55-DKniversity of Cologne1,500
已完成
3 期
HD212024-518022-33-00University Of Cologne1,320
进行中（未招募）
1 期
A study to improve the treatment in the first-line treatmend of advanced stage Hodgkin lymphomaTreatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-005130-55-SEniversity of Cologne1,500